Back to results

CompletedPhase 1

Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies.

NCT02947165

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Sarah Cannon Research Institute SC

Nashville, Tennessee, United States

+11 additional locations

View on ClinicalTrials.gov

Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies. — TrialFind